Principle Wealth Partners LLC lifted its position in UnitedHealth Group Inc (NYSE:UNH) by 16.1% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 3,741 shares of the healthcare conglomerate’s stock after purchasing an additional 519 shares during the period. Principle Wealth Partners LLC’s holdings in UnitedHealth Group were worth $813,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.
Other hedge funds have also modified their holdings of the company. Selective Wealth Management Inc. acquired a new stake in UnitedHealth Group during the third quarter worth approximately $27,000. North Star Investment Management Corp. purchased a new stake in shares of UnitedHealth Group in the 3rd quarter valued at about $30,000. Delta Asset Management LLC TN boosted its position in shares of UnitedHealth Group by 111.0% in the 3rd quarter. Delta Asset Management LLC TN now owns 154 shares of the healthcare conglomerate’s stock valued at $33,000 after purchasing an additional 81 shares during the period. Fusion Family Wealth LLC boosted its position in shares of UnitedHealth Group by 329.7% in the 3rd quarter. Fusion Family Wealth LLC now owns 159 shares of the healthcare conglomerate’s stock valued at $35,000 after purchasing an additional 122 shares during the period. Finally, Massey Quick Simon & CO. LLC grew its stake in UnitedHealth Group by 212.5% during the 3rd quarter. Massey Quick Simon & CO. LLC now owns 175 shares of the healthcare conglomerate’s stock worth $38,000 after buying an additional 119 shares during the last quarter. Institutional investors own 85.50% of the company’s stock.
In other news, EVP D Ellen Wilson sold 7,400 shares of the stock in a transaction on Monday, November 18th. The shares were sold at an average price of $272.77, for a total transaction of $2,018,498.00. Also, Director Richard T. Burke sold 25,000 shares of UnitedHealth Group stock in a transaction on Wednesday, October 16th. The shares were sold at an average price of $236.56, for a total transaction of $5,914,000.00. Following the completion of the sale, the director now directly owns 163,331 shares of the company’s stock, valued at approximately $38,637,581.36. The disclosure for this sale can be found here. Insiders sold a total of 38,577 shares of company stock worth $9,398,080 in the last three months. Company insiders own 0.82% of the company’s stock.
NYSE:UNH opened at $279.66 on Tuesday. The company has a current ratio of 0.70, a quick ratio of 0.70 and a debt-to-equity ratio of 0.67. The firm has a market capitalization of $265.15 billion, a PE ratio of 21.71, a price-to-earnings-growth ratio of 1.48 and a beta of 0.64. UnitedHealth Group Inc has a 52 week low of $208.07 and a 52 week high of $287.94. The stock has a 50 day moving average of $258.05 and a 200-day moving average of $245.34.
UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, October 15th. The healthcare conglomerate reported $3.88 EPS for the quarter, topping the consensus estimate of $3.75 by $0.13. The business had revenue of $60.35 billion during the quarter, compared to analyst estimates of $59.84 billion. UnitedHealth Group had a net margin of 5.57% and a return on equity of 25.30%. The company’s quarterly revenue was up 6.7% on a year-over-year basis. During the same quarter in the prior year, the firm earned $3.41 earnings per share. As a group, analysts predict that UnitedHealth Group Inc will post 14.96 EPS for the current fiscal year.
The company also recently declared a quarterly dividend, which will be paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th will be given a dividend of $1.08 per share. This represents a $4.32 annualized dividend and a dividend yield of 1.54%. The ex-dividend date is Friday, December 6th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 33.54%.
A number of equities analysts have recently issued reports on the stock. Mizuho restated a “buy” rating and set a $300.00 target price (up from $270.00) on shares of UnitedHealth Group in a research report on Tuesday, November 26th. Morgan Stanley reaffirmed a “buy” rating and set a $312.00 price target (up from $294.00) on shares of UnitedHealth Group in a report on Friday, November 22nd. SunTrust Banks reissued a “buy” rating and issued a $335.00 price objective (up from $310.00) on shares of UnitedHealth Group in a research note on Monday, November 18th. Cantor Fitzgerald set a $310.00 price objective on UnitedHealth Group and gave the company a “buy” rating in a report on Tuesday, October 15th. Finally, UBS Group cut their target price on UnitedHealth Group from $281.00 to $257.00 and set a “neutral” rating for the company in a research note on Thursday, October 17th. Five analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the stock. The stock presently has a consensus rating of “Buy” and an average target price of $289.39.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Further Reading: What is net income?